Latest / Bloomberg Law / Historic Opioid Settlement and New Name for NFL Team
Transcript
- 0:00Speaker 1: There's no end in sight to the opioid crisis. In fact,
- 0:03Speaker 1: there's been a startling increase in the number of opioid overdoses.
- 0:07Speaker 1: Here's Robert Califf during his hearing to become the Commissioner
- 0:10Speaker 1: of the f D. A opioid crisis and the addiction
- 0:14Speaker 1: crisis overall now is synthetic opioids and stimulants on the
- 0:20Speaker 1: streets of America. It's got wrenching for American families and
- 0:24Speaker 1: I think all of us know someone who's been affected
- 0:27Speaker 1: by it, and no group has been affected more than
- 0:30Speaker 1: Native Americans. But now a historic settlement, drug maker Johnson
- 0:35Speaker 1: and Johnson and the three largest US drug distributors have
- 0:39Speaker 1: agreed to pay five hundred ninety million dollars to four
- 0:42Speaker 1: hundred Native American tribes to settle lawsuits over the toll
- 0:46Speaker 1: of opioids. Joining me is healthcare attorney Harry Nelson, a
- 0:50Speaker 1: partner at Nelson Hardeman. Harry, what's the significance of this settlement?
- 0:55Speaker 1: Native American tribes were certainly the most hard hit group
- 0:59Speaker 1: in America from the standpoint of opioid harm. The numbers
- 1:03Speaker 1: of both overdose deaths and addiction rates and all kinds
- 1:07Speaker 1: of opioid suffering were without question worse in Native Americans
- 1:12Speaker 1: than probably any other demographic group. The tobacco industry deals
- 1:16Speaker 1: in the nineties left out Native Americans. So is this
- 1:20Speaker 1: a step forward an acknowledgement Native American tribes now have
- 1:25Speaker 1: a seat at the table. I think that's a good point.
- 1:27Speaker 1: In many ways, the opioid litigation had a lot of
- 1:31Speaker 1: lessons learned from previous mass court cases and particularly from
- 1:35Speaker 1: the too big tobacco cases. So I do think that
- 1:37Speaker 1: the fact that Native American tribes participated so broadly in
- 1:41Speaker 1: the multi district litigation was a reflection that they sort
- 1:44Speaker 1: of missed out on benefiting from the large chaoffs that
- 1:47Speaker 1: came through the tobacco litigation. So I do think it
- 1:50Speaker 1: was a tape where this community that is always hard
- 1:53Speaker 1: hit on, you know, whatever social ill you want to
- 1:55Speaker 1: talk about in America, was able to participate. I suppose
- 1:58Speaker 1: it's a positive development and progress of sometimes. W Ron Allen,
- 2:03Speaker 1: who's the chairman of a tribe in Washington State, called
- 2:06Speaker 1: it a big deal for the tribes to reach a settlement,
- 2:09Speaker 1: but said he doesn't expect his tribe of about five
- 2:11Speaker 1: hundred fifty people to get much help from the settlement.
- 2:15Speaker 1: Does that number five hundred and ninety million plus the
- 2:19Speaker 1: seventy five million reached in a separate settlement with the
- 2:22Speaker 1: Cherokee Nation, does that seem like fair compensation? Personally, I
- 2:27Speaker 1: think there's a high degree of arbitrary nous about what
- 2:30Speaker 1: the numbers are here. So on the one hand, it
- 2:32Speaker 1: sounds like a large number. On the other hand, when
- 2:33Speaker 1: you actually start measuring all of the loss of life,
- 2:37Speaker 1: the impact on families, on children growing up without parents,
- 2:40Speaker 1: all the law enforcement and healthcare services, it's like just
- 2:43Speaker 1: to drop in the bucket. So my guess is that
- 2:46Speaker 1: Judge Polster, you know, in getting both sides the table
- 2:49Speaker 1: had some realism about what was possible, not at all
- 2:53Speaker 1: based on the needs here or what the actual harm was,
- 2:56Speaker 1: but based on what the available resources from the total pool,
- 3:00Speaker 1: based on past settlements and the financial information provided by
- 3:03Speaker 1: the defendants. The deal will only take effect when of
- 3:08Speaker 1: the tribes with lawsuits against the companies agree to the settlement.
- 3:12Speaker 1: And this deal was negotiated by a group that represents
- 3:15Speaker 1: about so I'm wondering if it might pose a problem
- 3:19Speaker 1: to get that. My belief is that this settlement is,
- 3:25Speaker 1: you know, again in the scope of what was possible
- 3:28Speaker 1: was a reasonable outcome, and that it's going to take
- 3:32Speaker 1: a few more who knows, weeks, months of conversation with
- 3:37Speaker 1: some of the tribes that did not participate, but that
- 3:39Speaker 1: eventually they will come around. I think settling lawsuits, it's
- 3:43Speaker 1: much easier to start lawsuits than everybody has big dreams
- 3:46Speaker 1: of what's going to come with them, and settling laws
- 3:48Speaker 1: tricky because it forces everybody to compromise and figure out
- 3:52Speaker 1: what they can live with. My suspicion is that we
- 3:55Speaker 1: will see the necessary additional increment of tribes signing on
- 3:59Speaker 1: through some difficult conversations and coming to terms with the
- 4:03Speaker 1: fact that this is the best deal that's that's available.
- 4:06Speaker 1: So this is a settlement with J and J and
- 4:10Speaker 1: the three distributors. J and J is a manufacturer. What
- 4:14Speaker 1: were the distributors accused of? You know, the distributors are
- 4:17Speaker 1: really the middlemen of the industry. The drugs are manufactured
- 4:21Speaker 1: by companies like Perdue, and then they go to the
- 4:24Speaker 1: distributors under federal law and under the d e A structure,
- 4:28Speaker 1: and the distributors are the people who receive them from
- 4:30Speaker 1: the manufacturers and then ship them out mostly to pharmacies
- 4:34Speaker 1: and in some cases to physicians who are dispensing directly.
- 4:38Speaker 1: So you know, the real charge against the distributors was
- 4:41Speaker 1: that they turned a blind eye to large suspicious order
- 4:46Speaker 1: volume and they made a lot of money filling orders,
- 4:49Speaker 1: mostly from pharmacies, without really checking to see if the
- 4:53Speaker 1: orders were legitimate. Honestly, I think it's a complicated picture
- 4:56Speaker 1: about what. You know, the rules changed on the distributors.
- 4:59Speaker 1: So on the one hand, there is a case to
- 5:01Speaker 1: be made that they're not nearly in the same position
- 5:04Speaker 1: of culpability as manufacturers. Right, they weren't the ones who
- 5:07Speaker 1: marketed these drugs. They didn't make claims to the public.
- 5:10Speaker 1: They were just kind of a link in the chain.
- 5:13Speaker 1: On the other hand, they did make millions and millions
- 5:15Speaker 1: of dollars from the excessive dispensation of these drugs. So
- 5:20Speaker 1: you know, there's two sides of the story about how
- 5:22Speaker 1: bad the distributors really were. You really need a map
- 5:25Speaker 1: to figure out the opioid litigation. There are so many
- 5:28Speaker 1: pieces to it. So the tribes still have lawsuits pending
- 5:33Speaker 1: against pharmacy operators, including Walmart, CVS, and Walgreens. So you know,
- 5:39Speaker 1: pharmacies are in a somewhat related position to distributors in
- 5:43Speaker 1: the sense that they aren't the ones who made marketing
- 5:45Speaker 1: claim they were yet another link in the chain of
- 5:48Speaker 1: how the drugs got out there. By the way, many
- 5:51Speaker 1: many small pharmacies were omitted just because they're either not
- 5:53Speaker 1: in business anymore or the plaine employers didn't view them
- 5:56Speaker 1: as having the kind of resources that would be necessary
- 5:59Speaker 1: to settle. So in many ways, Walgreens and TVs are
- 6:02Speaker 1: sort of bearing the front of the anger and the
- 6:04Speaker 1: claims against pharmacies. So the pharmacies have been fighting hard.
- 6:07Speaker 1: Pharmacies were a late entrance into this case, you know,
- 6:11Speaker 1: years later than claims against drug manufacturers and distributors, and
- 6:14Speaker 1: I think it's very complicated. The reality is, if you
- 6:17Speaker 1: went back in time fifteen twenty years ago, nobody believed
- 6:21Speaker 1: that pharmacies had an obligation to police doctors. The claim
- 6:25Speaker 1: against distributors is that they didn't adequately police pharmacies. To
- 6:28Speaker 1: claim against pharmacies is that they didn't adequately police doctors.
- 6:32Speaker 1: And I think it speaks to a broken system when
- 6:35Speaker 1: everybody is supposed to be suspicious of the behavior of
- 6:39Speaker 1: the next level down, but you know everyone's got to
- 6:41Speaker 1: be looking over their shoulder. It just speaks to a
- 6:43Speaker 1: much bigger problem around pain prescribing and dispensation. And lawyers
- 6:48Speaker 1: for the Cherokee Nation are preparing for what maybe the
- 6:51Speaker 1: first trial of Native Americans claims against the retailers in
- 6:56Speaker 1: three and the last time the Cherokee Nations settled on
- 7:00Speaker 1: the eve of trial, so there's plenty of time for
- 7:02Speaker 1: this to be settled as well. Right. It's a very
- 7:05Speaker 1: high stick kind of negotiations going on because there definitely
- 7:09Speaker 1: are voices within the pharmacy retailers to fight and to
- 7:13Speaker 1: show that they really didn't do anything terrible here, that
- 7:16Speaker 1: there wasn't the kind of guilt that existed, for example,
- 7:19Speaker 1: with Perdue Pharma, and yet there's a massive liability. Right.
- 7:23Speaker 1: We did see the Oklahoma Johnson and Johnson decisions based
- 7:27Speaker 1: on a kind of public nuisance theory, you know, just
- 7:30Speaker 1: basically saying we don't know exactly what wrong was done,
- 7:33Speaker 1: but there was just a lot of harm here and
- 7:35Speaker 1: we're gonna hold you responsible. We saw that the court
- 7:37Speaker 1: was not receptive to that. My suspicion is that Walgreen
- 7:41Speaker 1: TVs are hanging tough because they feel like they have
- 7:46Speaker 1: good defenses here, But I still think settlement is always
- 7:49Speaker 1: the safest course. It gives everybody a guarantee about what
- 7:52Speaker 1: the outcome is and make sure that it's one that
- 7:53Speaker 1: they can live with. So I feel expect settlement, but
- 7:55Speaker 1: be a little ways off yet. So speaking about settlement,
- 7:59Speaker 1: let's tell about the global settlement of the same four
- 8:03Speaker 1: companies worth twenty six billion dollars with state and local
- 8:08Speaker 1: governments across the country. Where does that stand. A lot
- 8:11Speaker 1: of holding out right now on you know, Perdue pharma,
- 8:14Speaker 1: on the individual liability of the Stackler family. So I
- 8:18Speaker 1: think we're gonna be waiting to see a Federal Palace
- 8:22Speaker 1: decision to see whether whether the Sackler family is going
- 8:25Speaker 1: to be required to participate, whether they're going to be
- 8:28Speaker 1: given immunity, And I think that that decision is blowing
- 8:32Speaker 1: things down in terms of the ability to negotiate and
- 8:34Speaker 1: get a global resolution here. The global resolution isn't with Perdue,
- 8:38Speaker 1: is it. No? No, it's with everybody. But since the
- 8:41Speaker 1: Sackler family funds are a significant part, potentially you know,
- 8:45Speaker 1: billions and billions of more money that was taken out
- 8:48Speaker 1: of the country. Um, the my understanding is that that
- 8:52Speaker 1: that that that that that a number of the parties
- 8:53Speaker 1: are waiting to see what happened for the large billion
- 8:58Speaker 1: dollars settlement goes forward, and just remind us about what
- 9:01Speaker 1: happened with Purdue and the family and the bankruptcy. Yeah,
- 9:06Speaker 1: the family, Uh, you know, between something like two thousand
- 9:08Speaker 1: and nine, two thousand eight or two thousand and two
- 9:11Speaker 1: thousand seventeen, the family took between ten and eleven billion
- 9:15Speaker 1: dollars out of the country. Uh, put it into offshore
- 9:19Speaker 1: accounts and other financial vehicles where they believed they would
- 9:23Speaker 1: be protected because they were already at that point gearing up,
- 9:27Speaker 1: they were anticipating litigation. Perdue had already reached the settlement
- 9:30Speaker 1: for its behavior even though it was continuing. So there's
- 9:32Speaker 1: a lot of money that the Sackler's, you know, we're
- 9:35Speaker 1: able to essentially take off and protect and make them
- 9:38Speaker 1: one of the wealthiest families in America. And uh, we
- 9:41Speaker 1: still have a serious effort underway to squad effect in
- 9:46Speaker 1: the bankruptcy proceeding. The family basically took an all or
- 9:49Speaker 1: nothing position and said they would not settle, which would
- 9:52Speaker 1: mean there would be no really no money coming from
- 9:54Speaker 1: Purduke because they had not left any money in the
- 9:56Speaker 1: company unless the entire family was given immu city and
- 10:00Speaker 1: so that was what the bankruptcy judge, Judge Drain negotiated
- 10:04Speaker 1: UM and not unhappily. The judge was very outspoken that
- 10:07Speaker 1: he didn't think it was it was fair, but it
- 10:09Speaker 1: was basically what was possible. So the family hadn't successfully
- 10:12Speaker 1: negotiated immunity and then UM on appeal it was reversed
- 10:16Speaker 1: as as being an excessive decision outside of the power
- 10:20Speaker 1: of the bankruptcy court, and that the family should still
- 10:23Speaker 1: face immunity, that they couldn't be protected in the way
- 10:26Speaker 1: that the settlement had tried to do. So it's a
- 10:28Speaker 1: very very interesting question, you know. I think in some
- 10:31Speaker 1: ways maybe the most interesting question about the whole opioid
- 10:34Speaker 1: litigation is how much this family can protect itself when
- 10:38Speaker 1: it made so much money um and really was in
- 10:41Speaker 1: many ways the catalyst for this terrible crisis. Would you
- 10:45Speaker 1: compare the opioid litigation to the Depaco litigation or is
- 10:49Speaker 1: it different? You know, I think there is a lot
- 10:53Speaker 1: of similarity in the sense that these were products that
- 10:57Speaker 1: had you know, significant social harm associated with them. I mean,
- 11:01Speaker 1: the difference opioids I think are more complicated. Right, tobacco,
- 11:05Speaker 1: There's nobody who claims that tobacco has health benefits or
- 11:08Speaker 1: that it's in the necessary thing. The reality is that
- 11:12Speaker 1: it's a vice that's popular with millions and millions of Americans,
- 11:16Speaker 1: and and it was much I think it was much
- 11:17Speaker 1: easier to just put tough restrictions on tobacco. Opioids are
- 11:22Speaker 1: more complicated because there are millions of people out there
- 11:25Speaker 1: who are suffering in pain, who need these, and so
- 11:28Speaker 1: I think it's a much murkier picture of where doctors
- 11:32Speaker 1: went wrong, of where pharmacies and distributors went wrong. You know,
- 11:35Speaker 1: it's easy to point fingers that companies like Perdue because
- 11:38Speaker 1: they were so grossly you know, uh, their behavior was
- 11:41Speaker 1: so troubling in terms of how they dismissed rising death poles.
- 11:45Speaker 1: But I think opioids are more complicated. And on the
- 11:48Speaker 1: settlement side, the tobacco settlements are widely viewed as a
- 11:51Speaker 1: disaster in the sense that almost none of the money
- 11:53Speaker 1: actually went into anti tobacco programs. Instead, state government used
- 11:58Speaker 1: it to fill their budget hole. I think like something
- 12:01Speaker 1: like three percent of the total tobacco settlements actually went
- 12:03Speaker 1: into anti tobacco or tobacco health related program. My hope
- 12:07Speaker 1: is that the opioid settlement will actually go towards improving
- 12:12Speaker 1: public health and dealing with a much much more complicated
- 12:15Speaker 1: issue of how we balance the need for the drugs
- 12:18Speaker 1: against the dangers that they posed. Thanks Harry, that's Harry
- 12:22Speaker 1: Nelson of Nelson Hardeman, Battle Chested Leader one or nine
- 12:30Speaker 1: community is in this room. We are the commanding. The
- 12:40Speaker 1: Washington football team announced its new name this week. It
- 12:44Speaker 1: took eighteen months from the time it dropped the name Redskins,
- 12:47Speaker 1: which Native American groups found offensive. The team even had
- 12:51Speaker 1: a video explaining the difficulties in coming up with a
- 12:54Speaker 1: new name, including the legal challenges searching the intellectual property
- 12:59Speaker 1: lands eight this extraordinarily complicated for something like this that's
- 13:03Speaker 1: going to be this famous and this widely used, and
- 13:06Speaker 1: how did they keep the name secret through the long process.
- 13:10Speaker 1: Sports franchises resort to extreme legal maneuvers to protect a
- 13:14Speaker 1: new name and brand. Joining me to discuss the process
- 13:17Speaker 1: is Susan Decker, Bloomberg Patents reporter. So Sue tell us
- 13:21Speaker 1: about some of the legal tactics the teams used to
- 13:23Speaker 1: prevent the name from getting out ahead of time. They're
- 13:26Speaker 1: going to file their trademark application in another country. They're
- 13:30Speaker 1: going to file in Trinidad and Tobago and Mauritius, like
- 13:33Speaker 1: these island nations that don't have a whole lot of
- 13:35Speaker 1: internet access and don't have a lot of public access
- 13:38Speaker 1: and have policies that don't allow them to be public.
- 13:40Speaker 1: This way you get the protection because the trademark application
- 13:44Speaker 1: is good from the date of the first application, but
- 13:47Speaker 1: you don't actually file the application in this country that
- 13:50Speaker 1: has public access like the US, for six months. You
- 13:53Speaker 1: have that six months lead time so that you can
- 13:56Speaker 1: get everything together. You have the protection, but you can
- 13:58Speaker 1: get all of your splashing mark marketing stuff all together
- 14:01Speaker 1: and then announce it. And when you announce it, you're
- 14:04Speaker 1: still protected and you're not going to have to worry
- 14:06Speaker 1: about someone running to the trademark office to file an
- 14:09Speaker 1: application on the name that you've chosen. And what are
- 14:11Speaker 1: the favorite countries to file in right now? It's Tanka
- 14:15Speaker 1: and Mauritius. It used to be a lot of the
- 14:18Speaker 1: Caribbean nations were very popular. Jamaica used to be number one,
- 14:22Speaker 1: and then they upgraded their system so people stop filing
- 14:25Speaker 1: in Jamaica, se Tonga Mauritius both have a policy that
- 14:28Speaker 1: if you want to look at the applications, you have
- 14:30Speaker 1: to physically go there and look at the applications and tongue.
- 14:35Speaker 1: As a matter of fact, you can only request that
- 14:37Speaker 1: the employee of the trademark office do the searching for you,
- 14:41Speaker 1: and they may or may not be willing to do that.
- 14:43Speaker 1: And what they do allow the public to see isn't
- 14:46Speaker 1: available for weeks and sometimes months. So you can try
- 14:50Speaker 1: to hire somebody in Mauritius to scope out the trademark office,
- 14:53Speaker 1: but they're not going to be all that successful. And
- 14:56Speaker 1: the Cleveland Major League Baseball club filed in Mauritius. They
- 15:01Speaker 1: filed in Mauritius. Yes, and they filed into their own
- 15:04Speaker 1: name under the Cleveland Indians name, which was their former team.
- 15:07Speaker 1: Some companies, like Apple, what they do is they'll set
- 15:10Speaker 1: up a shell company and they'll set up a company
- 15:13Speaker 1: that has some innocuous name like I T Management, and
- 15:16Speaker 1: they'll file the application. In Apple's case, they filed it
- 15:20Speaker 1: and turn it out tobacco for the iPad. They filed
- 15:23Speaker 1: it under this innocuous sounding name in this remote trademark
- 15:28Speaker 1: office and then when they were ready to announce the product,
- 15:30Speaker 1: they filed their application in the US and then they
- 15:33Speaker 1: quickly had that company subsumed into the Apple Company so
- 15:36Speaker 1: that there was no concern about ownership rights. Does that
- 15:40Speaker 1: give an added layer of protection? Yeah. If you're going
- 15:43Speaker 1: to turn it out in Tobago to look for trademark applications,
- 15:47Speaker 1: you know you're going to look for something by Apple,
- 15:49Speaker 1: so you're not gonna be able to find it. It's
- 15:50Speaker 1: going to be much more difficult to find. You're going
- 15:53Speaker 1: to have to guess what the name is and then
- 15:54Speaker 1: try and put them together. And there's a kind of
- 15:57Speaker 1: a little marketplace of company sort of individuals that are
- 16:01Speaker 1: filing trademark applications on names that they think somebody will
- 16:05Speaker 1: try to use. There called trademark squatters, and what they
- 16:08Speaker 1: do is they file save for instance, you're going to
- 16:11Speaker 1: set up a company called Grasso Inc. And you're going
- 16:14Speaker 1: to be a big splash company. I would go and
- 16:17Speaker 1: I would file maybe grass Ola, and I'm going to
- 16:20Speaker 1: file a trademark application for grassol a. But that's the
- 16:24Speaker 1: name you want to use, So you're gonna pay me
- 16:26Speaker 1: to turn over those rights because I've filed the application,
- 16:30Speaker 1: and what kind of trademark searches do you have to
- 16:33Speaker 1: do before you decide on a name. You need to
- 16:36Speaker 1: get the trademark on all the merchandise, on the video rights,
- 16:41Speaker 1: on the TV rights, you need to get the websites,
- 16:43Speaker 1: you need to get the social media accounts, and you
- 16:45Speaker 1: need to make sure that you can get the same
- 16:48Speaker 1: name for all of these things. And in trademarks in particular,
- 16:52Speaker 1: the trademark is only for a specific type of good.
- 16:56Speaker 1: That's why, for instance, you can have Delta Faucets and
- 16:58Speaker 1: Delta Airlines because their different companies in different areas, but
- 17:02Speaker 1: they still have the Delta name. So when you have
- 17:04Speaker 1: the Washington football team or any football team, you have
- 17:07Speaker 1: to have that name that can be used for cups
- 17:10Speaker 1: and hats and clothing and software and products that football
- 17:16Speaker 1: teams or any sports teams used for branding purposes. And
- 17:19Speaker 1: you see that they just had a minefield that they
- 17:21Speaker 1: had to go through. They explain that minefield in the
- 17:25Speaker 1: video and they have their chief legal officer, Damon Jones,
- 17:29Speaker 1: explaining why they couldn't use a fan favorite name, which
- 17:34Speaker 1: was Wolves or Red Wolves. Yeah, it is a minefield.
- 17:37Speaker 1: There's variations of the name wolves for a lot of products,
- 17:41Speaker 1: and you want to make sure that you have those
- 17:43Speaker 1: clear rights. Trademarker is something used by the brand owner
- 17:47Speaker 1: to protect their property. Once the trademark is registered, do
- 17:51Speaker 1: you have a lot of legal rights to shut off
- 17:53Speaker 1: counterfeiters and you want to make sure you have that registration.
- 17:57Speaker 1: You can get a common law trademark. Anybody can have that,
- 18:00Speaker 1: there's millions of them. But you want to have that
- 18:02Speaker 1: registered trademark, and the Patent Trademark Office will only give
- 18:05Speaker 1: it if it's unique and only for that good. So
- 18:08Speaker 1: you want to have the trademark registered for anything you're
- 18:12Speaker 1: going to sell. And you know there's only so many
- 18:15Speaker 1: words in the English language that would attract football players. Apparently, well,
- 18:19Speaker 1: they want a lot for this name. When they talk
- 18:21Speaker 1: about what they want for this name, it's it's a
- 18:23Speaker 1: lot to go into a few words. So now I
- 18:26Speaker 1: was really interested. You wrote that well known companies are
- 18:29Speaker 1: used to having their trademark filing scrutinized for insight into
- 18:33Speaker 1: their future plans, like Walmart and Pepsi. Yes, so in
- 18:38Speaker 1: the cases of the recent Walmart trademark applications, and that's
- 18:42Speaker 1: an expansion of the existing Walmart name. So it's not
- 18:45Speaker 1: like they're coming up with a new name in Walmart
- 18:48Speaker 1: has been kind of obvious that they were going to
- 18:51Speaker 1: get into this field. This is more of a confirmation
- 18:55Speaker 1: of what people had already suspected, so they weren't as
- 18:58Speaker 1: concerned about keeping its secret. Whereas if you have something
- 19:01Speaker 1: that's totally new to the field, new to the company,
- 19:05Speaker 1: a new product, that's when you're going to to go
- 19:07Speaker 1: ahead and go through these extra steps of filing overseas
- 19:12Speaker 1: and Pepsi. Pepsi bought the rock Star brand, and so
- 19:15Speaker 1: it was that they were getting into speculation they're going
- 19:17Speaker 1: to get into alcoholic beverages because of course hard cider
- 19:21Speaker 1: um is very popular and all these hard drinks, hard
- 19:23Speaker 1: lemonade and things like that you see coming out. But
- 19:26Speaker 1: I have to say, sometimes, you know, it's anti chimactic.
- 19:29Speaker 1: Like with the Cleveland Guardians. I was expecting a name
- 19:33Speaker 1: that was going to really sizzle, and then I heard
- 19:35Speaker 1: Guardians and I thought, Okay, the thing is that they
- 19:38Speaker 1: want to have and that's the problem that they're going
- 19:41Speaker 1: to have is they need to have a name that's
- 19:43Speaker 1: going to be evocative of something strong, and you know,
- 19:47Speaker 1: tought and things like that. You know that you think
- 19:49Speaker 1: about the drugmakers and their efforts to come up with names.
- 19:53Speaker 1: They have to come up with a name is going
- 19:54Speaker 1: to be approved by the FDA that isn't confusing similar
- 19:58Speaker 1: to any other drug. They have to actually makeup names
- 20:01Speaker 1: they can't use like a common name. So that's why
- 20:04Speaker 1: you get all of these bizarre drug names with xes
- 20:07Speaker 1: and these. And there was a brand developer told me
- 20:11Speaker 1: years and years ago that the reason why there are
- 20:14Speaker 1: so many exes and zs and vs in um drug
- 20:17Speaker 1: names is because someone did a study that subconsciously the
- 20:22Speaker 1: mind thinks that that's a strong word, so like the
- 20:25Speaker 1: hard syllables. And that's why you see so many drugs
- 20:28Speaker 1: with those those constant the names you can pronounce, yeah,
- 20:31Speaker 1: and the names you can't pronounce yeah. Thanks so much, Sue.
- 20:34Speaker 1: That's Susan Decker, Bloomberg Patents Reporter. And that's it for
- 20:38Speaker 1: the edition of the Bloomberg Law Show. Remember you can
- 20:40Speaker 1: always get the latest legal news by listening to our
- 20:43Speaker 1: Bloomberg Law Podcast wherever you get your favorite podcasts. I'm
- 20:47Speaker 1: June Grosso and you're listening to Bloomberg